Testolactone aqueous suspension (Teslac).
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D006801:Humans; D007783:Lactones / Q000008:administration & dosage*; D008297:Male; D051379:Mice; D010616:Phenanthrenes / Q000008:administration & dosage*; D011817:Rabbits; D051381:Rats; D013738:Testolactone / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity
D000970:Antineoplastic Agents; D007783:Lactones; D010616:Phenanthrenes; D013738:Testolactone